The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices,” which provides advice for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback